Mar. 9 at 3:08 PM
Agilent Technologies announced it will acquire privately held clinical pathology firm Biocare Medical for
$950 million in cash. The deal strengthens Agilent’s position in immunohistochemistry, a cancer diagnostic technique that uses antibodies to detect abnormal cells.
Biocare Medical offers integrated tissue-diagnostics tools used for cancer and infectious disease testing, with government and military laboratories among its customers. Agilent said the acquisition should boost revenue growth and profit margins in the first year while increasing its share of consumables and services sales.
The transaction is expected to close by the end of the fourth quarter of 2026, subject to regulatory approval.
$A